| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.25B | 2.25B | 1.79B | 1.18B | 593.31M | 251.91M |
| Gross Profit | 412.98M | 422.61M | 279.10M | 209.50M | 99.65M | 10.45M |
| EBITDA | -56.15M | -48.00M | -60.07M | -189.85M | -134.39M | -117.89M |
| Net Income | -16.94M | -16.94M | -13.49M | -23.87M | -79.00M | -122.31M |
Balance Sheet | ||||||
| Total Assets | 2.40B | 2.40B | 1.58B | 1.05B | 631.26M | 280.54M |
| Cash, Cash Equivalents and Short-Term Investments | 1.24B | 1.24B | 727.31M | 545.51M | 353.46M | 156.63M |
| Total Debt | 31.68M | 31.68M | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.92B | 1.92B | 1.19B | 1.05B | 562.32M | 1.39B |
| Stockholders Equity | 221.32M | 221.32M | 197.23M | 82.00K | 7.18M | -1.11B |
Cash Flow | ||||||
| Free Cash Flow | 787.91M | 787.91M | -102.45M | 209.47M | -166.20M | 97.40M |
| Operating Cash Flow | 866.94M | 866.94M | -58.08M | 230.79M | -148.25M | 109.57M |
| Investing Cash Flow | -350.74M | -350.74M | 156.48M | -299.46M | -17.95M | -12.17M |
| Financing Cash Flow | 668.00K | 668.00K | 371.04M | -24.10M | 362.45M | 0.00 |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $27.35B | 12.42 | 15.88% | 1.04% | -5.24% | 45.69% | |
75 Outperform | $16.37B | 26.15 | 17.97% | 0.96% | 0.83% | -1.32% | |
71 Outperform | $46.02B | 52.66 | 24.24% | 1.33% | 0.98% | -7.51% | |
69 Neutral | $32.13B | 62.59 | 5.35% | 0.10% | 4.20% | -34.47% | |
67 Neutral | $34.46B | 26.63 | ― | 1.88% | 0.73% | -15.57% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | $41.76B | -453.21 | -8.09% | ― | 24.80% | -31.37% |
On December 8, 2025, Symbotic Inc. completed an underwritten offering of 11,500,000 shares of Class A common stock, raising approximately $425 million in net proceeds for general corporate purposes. The offering included shares sold by both the company and selling securityholders, with the company not receiving proceeds from the latter’s sales. This strategic financial move is expected to bolster Symbotic’s operational capabilities and market positioning.
The most recent analyst rating on (SYM) stock is a Sell with a $41.00 price target. To see the full list of analyst forecasts on Symbotic stock, see the SYM Stock Forecast page.
On November 24, 2025, Symbotic Inc. announced its financial results for the fourth quarter and fiscal year 2025, ending September 27, 2025. The company reported a revenue increase to $618 million for the quarter, despite a net loss of $19 million, with adjusted EBITDA rising to $49 million. For the full year, revenue grew by 26% to $2,247 million, though the company faced a net loss of $91 million. Symbotic’s cash reserves increased significantly, and the company expanded into the healthcare sector by adding Medline as a customer. Looking forward, Symbotic anticipates continued growth and strong financial performance in fiscal year 2026, with expected revenue between $610 million and $630 million for the first quarter.
The most recent analyst rating on (SYM) stock is a Buy with a $83.00 price target. To see the full list of analyst forecasts on Symbotic stock, see the SYM Stock Forecast page.